INTECH INVESTMENT MANAGEMENT LLC
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1086318
WEST PALM BEACH, FL
Position in INDV
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,711,043
New position
Shares Held
88,945
first reported quarter
Ownership
0.073%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026INTECH INVESTMENT MANAGEMENT LLC holds $94,314,635 across 29 Drug Manufacturers - Specialty & Generic names. INDV ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
311,871 | $36,866,270 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
478,939 | $14,425,641 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
20,744 | $12,300,776 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
86,315 | $11,371,137 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
44,826 | $3,400,052 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
88,945 | $2,711,043 | |
| 7 | ALKS |
Alkermes plc.
|
60,967 | $2,155,793 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38,984 | $2,015,082 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,711,043 | 88,945 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||